Gakhar B, Spencer AL Using direct observation, formal evaluation, and an interactive curriculum to improve the sign-out practices of internal medicine interns. Acad Med. 2010 Jul;85(7):1182-8. doi: 10.1097/ACM.0b013e3181da8370.
Gordon M, Findley R Educational interventions to improve handover in health care: a systematic review. Med Educ. 2011 Nov;45(11):1081-9. doi: 10.1111/j.1365-2923.2011.04049.x. Epub 2011 Sep 20. Review.
Horwitz LI, Krumholz HM, Green ML, Huot SJ Transfers of patient care between house staff on internal medicine wards: a national survey. Arch Intern Med. 2006 Jun 12;166(11):1173-7.
Horwitz LI, Moin T, Green ML Development and implementation of an oral sign-out skills curriculum. J Gen Intern Med. 2007 Oct;22(10):1470-4. Epub 2007 Aug 3.
Klamen DL, Reynolds KL, Yale B, Aiello M Students learning handovers in a simulated in-patient unit. Med Educ. 2009 Nov;43(11):1097-8. doi: 10.1111/j.1365-2923.2009.03488.x. Epub 2009 Oct 3.
Laine C, Goldman L, Soukup JR, Hayes JG The impact of a regulation restricting medical house staff working hours on the quality of patient care. JAMA. 1993 Jan 20;269(3):374-8.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
